A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy

Status Completed

Clinical Trial Summary

Clinical Trial Description

Recent data suggest that areas of fibrosis and hibernating myocardium develop in patients with non ischemic dilated cardiomyopathy. Ranolazine is a new drug, developed to releave symptoms of angina in patients with stable coronary disease that is not suitable for surgical or percutaneous revascularization. The main mechanism of action of Ranolazine is the inhibition of late I(Na) thus decreasing the Ca++ load in the cardiomyocites. Consequently oxygen consumption also decreases. It has also been shown that in patients with stable coronary disease Ranolazine improves myocardial perfusion as shown with myocardial nuclear imaging. The aim of this trial is to evaluate effects of ranolazine on myocardial perfusion in patients with dilated cardiomyopathy. Primary end-point: To determine wheather Ranolazine improves perfusion of the myocardium in patients with non-ischemic dilated cardiomyopathy. Secondary end-points: To determine wheather Ranolazine improves patients' NYHA functional class, excercise capacity, LV systolic and diastolic function and weather ranolazine affects supraventricular and ventricular arrhythmia occurance/frequency. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02133911
Study type	Interventional
Source	University Medical Centre Ljubljana
Contact
Status	Completed
Phase	Phase 2
Start date	May 1, 2014
Completion date	April 2, 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05564689` - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
Recruiting	`NCT04982081` - Treating Congestive HF With hiPSC-CMs Through Endocardial Injection	Phase 1
Not yet recruiting	`NCT04703751` - Evaluation of the CIRCULATE Catheter for Transcoronary Administration of Pharmacologic and Cell-based Agents	N/A
Recruiting	`NCT01157299` - Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO	N/A
Completed	`NCT00765518` - Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)	Phase 2
Completed	`NCT02115581` - Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy	Phase 4
Recruiting	`NCT04246450` - Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy	N/A
Recruiting	`NCT05799833` - Low QRS Voltages in Young Healthy Individuals and Athletes
Recruiting	`NCT01914081` - Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to Bedside	Phase 3
Recruiting	`NCT02915718` - A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy	N/A
Recruiting	`NCT03061994` - Metabolomic Study of All-age Cardiomyopathy	N/A
Completed	`NCT03893760` - Assessment of Right Ventricular Function in Advanced Heart Failure
Not yet recruiting	`NCT01219452` - Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy	Phase 1/Phase 2
Recruiting	`NCT02175836` - Arrhythmia Prediction Trial	N/A
Active, not recruiting	`NCT00962364` - Long-term Evaluation of Patients Receiving Bone Marrow-derived Cell Administration for Heart Disease
Recruiting	`NCT05026112` - The Arrhythmogenic Potential of Midwall Septal Fibrosis in Dilated Cardiomyopathy
Recruiting	`NCT05237323` - Micophenolate Mofetil Versus Azathioprine in Myocarditis	Phase 3
Recruiting	`NCT04649034` - Intraventricular Stasis In Cardiovascular Disease
Suspended	`NCT03071653` - Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study	Phase 2
Completed	`NCT02619825` - Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie)	N/A

A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy — RAMP-DCM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms